

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | interferon-gamma production (GO:0032609) | 9.45518757 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.35314256 |
| 3 | negative T cell selection (GO:0043383) | 7.27075593 |
| 4 | negative thymic T cell selection (GO:0045060) | 7.24205666 |
| 5 | negative regulation of cell killing (GO:0031342) | 6.97005121 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.97005121 |
| 7 | positive thymic T cell selection (GO:0045059) | 6.62403502 |
| 8 | regulation of isotype switching to IgG isotypes (GO:0048302) | 6.44991160 |
| 9 | regulation of natural killer cell mediated immunity (GO:0002715) | 6.32335125 |
| 10 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 6.32335125 |
| 11 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.28236948 |
| 12 | thymic T cell selection (GO:0045061) | 6.08459960 |
| 13 | * response to interleukin-15 (GO:0070672) | 5.93244874 |
| 14 | positive T cell selection (GO:0043368) | 5.85272691 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.83677141 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.83677141 |
| 17 | tolerance induction (GO:0002507) | 5.66199830 |
| 18 | regulation of gamma-delta T cell activation (GO:0046643) | 5.61229280 |
| 19 | T cell migration (GO:0072678) | 5.58901425 |
| 20 | activated T cell proliferation (GO:0050798) | 5.43480566 |
| 21 | T cell selection (GO:0045058) | 5.41693616 |
| 22 | cytolysis (GO:0019835) | 5.19586127 |
| 23 | * cellular response to interleukin-15 (GO:0071350) | 5.14754887 |
| 24 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.13888979 |
| 25 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 5.11274629 |
| 26 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 5.11274629 |
| 27 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.10215883 |
| 28 | leukocyte aggregation (GO:0070486) | 5.10157038 |
| 29 | regulation of T cell tolerance induction (GO:0002664) | 5.09281197 |
| 30 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 5.02108919 |
| 31 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.93668446 |
| 32 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.84676465 |
| 33 | natural killer cell activation (GO:0030101) | 4.69219351 |
| 34 | T cell receptor signaling pathway (GO:0050852) | 4.66477625 |
| 35 | T cell costimulation (GO:0031295) | 4.65926129 |
| 36 | positive regulation of isotype switching (GO:0045830) | 4.63348799 |
| 37 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.60509371 |
| 38 | lymphocyte costimulation (GO:0031294) | 4.57335432 |
| 39 | regulation of cell killing (GO:0031341) | 4.57062751 |
| 40 | cellular defense response (GO:0006968) | 4.50924630 |
| 41 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.34032320 |
| 42 | positive regulation of tolerance induction (GO:0002645) | 4.24136213 |
| 43 | positive regulation of cell killing (GO:0031343) | 4.17520169 |
| 44 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.16993946 |
| 45 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 4.14314706 |
| 46 | positive regulation of B cell mediated immunity (GO:0002714) | 4.14314706 |
| 47 | negative regulation of T cell mediated immunity (GO:0002710) | 4.12371445 |
| 48 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.10080570 |
| 49 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 4.05848800 |
| 50 | regulation of response to interferon-gamma (GO:0060330) | 4.04191607 |
| 51 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.01172517 |
| 52 | regulation of isotype switching (GO:0045191) | 3.96356481 |
| 53 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.94377548 |
| 54 | B cell receptor signaling pathway (GO:0050853) | 3.94025820 |
| 55 | positive regulation of DNA recombination (GO:0045911) | 3.93789950 |
| 56 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.88994943 |
| 57 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.88067045 |
| 58 | positive regulation of humoral immune response (GO:0002922) | 3.86550133 |
| 59 | regulation of memory T cell differentiation (GO:0043380) | 3.86529773 |
| 60 | type I interferon signaling pathway (GO:0060337) | 3.84814521 |
| 61 | cellular response to type I interferon (GO:0071357) | 3.84814521 |
| 62 | response to type I interferon (GO:0034340) | 3.82767231 |
| 63 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.81648682 |
| 64 | alpha-beta T cell activation (GO:0046631) | 3.77151331 |
| 65 | positive regulation of interleukin-2 production (GO:0032743) | 3.75591358 |
| 66 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.74609302 |
| 67 | alpha-beta T cell differentiation (GO:0046632) | 3.74264316 |
| 68 | regulation of regulatory T cell differentiation (GO:0045589) | 3.71537873 |
| 69 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.67652110 |
| 70 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.67652110 |
| 71 | T cell differentiation involved in immune response (GO:0002292) | 3.67652110 |
| 72 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.66766928 |
| 73 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.65991731 |
| 74 | regulation of tolerance induction (GO:0002643) | 3.65726993 |
| 75 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.65459855 |
| 76 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.63729580 |
| 77 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.62700738 |
| 78 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.62571352 |
| 79 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.62571352 |
| 80 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.62571352 |
| 81 | modulation by symbiont of host immune response (GO:0052553) | 3.62571352 |
| 82 | positive regulation by symbiont of host defense response (GO:0052509) | 3.62571352 |
| 83 | modulation by symbiont of host defense response (GO:0052031) | 3.62571352 |
| 84 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.61368735 |
| 85 | regulation of B cell mediated immunity (GO:0002712) | 3.60888909 |
| 86 | detection of bacterium (GO:0016045) | 3.56467743 |
| 87 | response to muramyl dipeptide (GO:0032495) | 3.54572650 |
| 88 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.52350891 |
| 89 | T-helper cell differentiation (GO:0042093) | 3.52350891 |
| 90 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.51653448 |
| 91 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.51562959 |
| 92 | immunoglobulin mediated immune response (GO:0016064) | 3.47712610 |
| 93 | leukocyte cell-cell adhesion (GO:0007159) | 3.47070318 |
| 94 | lymphocyte migration (GO:0072676) | 3.46816687 |
| 95 | negative regulation of innate immune response (GO:0045824) | 3.45386323 |
| 96 | T cell differentiation (GO:0030217) | 3.45156270 |
| 97 | positive regulation of interferon-gamma production (GO:0032729) | 3.43657612 |
| 98 | regulation of B cell differentiation (GO:0045577) | 3.41917821 |
| 99 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.41220245 |
| 100 | positive regulation of B cell differentiation (GO:0045579) | 3.40617667 |
| 101 | detection of other organism (GO:0098543) | 3.40479634 |
| 102 | positive regulation of immunoglobulin production (GO:0002639) | 3.40434148 |
| 103 | cellular extravasation (GO:0045123) | 3.40430599 |
| 104 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.40274546 |
| 105 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.38243094 |
| 106 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.36806159 |
| 107 | T cell homeostasis (GO:0043029) | 3.36174463 |
| 108 | T cell activation involved in immune response (GO:0002286) | 3.32293181 |
| 109 | positive regulation of defense response to virus by host (GO:0002230) | 3.29138668 |
| 110 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.24431548 |
| 111 | T cell proliferation (GO:0042098) | 3.24063115 |
| 112 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.23112534 |
| 113 | T cell activation (GO:0042110) | 3.16765002 |
| 114 | regulation of immunoglobulin production (GO:0002637) | 3.16737141 |
| 115 | NIK/NF-kappaB signaling (GO:0038061) | 3.16398507 |
| 116 | neutrophil activation involved in immune response (GO:0002283) | 3.15551279 |
| 117 | macrophage activation involved in immune response (GO:0002281) | 3.15156146 |
| 118 | natural killer cell differentiation (GO:0001779) | 3.14242590 |
| 119 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.13444946 |
| 120 | mast cell activation (GO:0045576) | 3.13376750 |
| 121 | regulation of T-helper 1 type immune response (GO:0002825) | 3.13209128 |
| 122 | positive regulation of granulocyte differentiation (GO:0030854) | 3.12017125 |
| 123 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.11925067 |
| 124 | regulation of T cell mediated immunity (GO:0002709) | 3.10842456 |
| 125 | heterotypic cell-cell adhesion (GO:0034113) | 3.10704369 |
| 126 | B cell homeostasis (GO:0001782) | 3.10598601 |
| 127 | positive regulation of T cell mediated immunity (GO:0002711) | 3.10522861 |
| 128 | Peyers patch development (GO:0048541) | 3.10042124 |
| 129 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.10042124 |
| 130 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.08491204 |
| 131 | regulation of interleukin-2 production (GO:0032663) | 3.08071896 |
| 132 | leukocyte degranulation (GO:0043299) | 3.07604078 |
| 133 | positive regulation of leukocyte mediated immunity (GO:0002705) | 3.05704055 |
| 134 | negative regulation of interleukin-12 production (GO:0032695) | 3.05348600 |
| 135 | negative regulation of phagocytosis (GO:0050765) | 3.04166380 |
| 136 | regulation of alpha-beta T cell activation (GO:0046634) | 3.02787911 |
| 137 | B cell mediated immunity (GO:0019724) | 3.01063184 |
| 138 | myeloid dendritic cell differentiation (GO:0043011) | 2.99037276 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.62582381 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.71440922 |
| 3 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.48645106 |
| 4 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 4.23349875 |
| 5 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.99290232 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 3.57180439 |
| 7 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.56510592 |
| 8 | MYB_26560356_Chip-Seq_TH2_Human | 3.56099845 |
| 9 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.48994018 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.24599091 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.20131147 |
| 12 | MAF_26560356_Chip-Seq_TH1_Human | 3.13820728 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.06211537 |
| 14 | MYB_26560356_Chip-Seq_TH1_Human | 3.06150958 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.00638010 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.99371743 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.92903406 |
| 18 | UTX_26944678_Chip-Seq_JUKART_Human | 2.78711789 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.44713206 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.40148195 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.36871771 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.28161130 |
| 23 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.23100234 |
| 24 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.19379402 |
| 25 | MAF_26560356_Chip-Seq_TH2_Human | 2.17845621 |
| 26 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.17230190 |
| 27 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.15473085 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.10179479 |
| 29 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.06756045 |
| 30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.98148794 |
| 31 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.96627390 |
| 32 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.95627405 |
| 33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.93459896 |
| 34 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.92997315 |
| 35 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.86131312 |
| 36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.82918580 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.82188981 |
| 38 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.81702003 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.80865771 |
| 40 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.80277757 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.70902860 |
| 42 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.68586270 |
| 43 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.66937592 |
| 44 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.63508518 |
| 45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.63259518 |
| 46 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.62620949 |
| 47 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.60255248 |
| 48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.54194209 |
| 49 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.45134627 |
| 50 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.42190940 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41386978 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.39511922 |
| 53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.36522074 |
| 54 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.34072785 |
| 55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28596975 |
| 56 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.27910243 |
| 57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.27169606 |
| 58 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.24668559 |
| 59 | GATA3_26560356_Chip-Seq_TH2_Human | 1.24350778 |
| 60 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21983487 |
| 61 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19815782 |
| 62 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17449805 |
| 63 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.16280049 |
| 64 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.15151720 |
| 65 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.14815689 |
| 66 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.14127670 |
| 67 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.12677980 |
| 68 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08448816 |
| 69 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07090987 |
| 70 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06203777 |
| 71 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03986886 |
| 72 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02982044 |
| 73 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.98808185 |
| 74 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97709176 |
| 75 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.97453092 |
| 76 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.96173738 |
| 77 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94705671 |
| 78 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.94659733 |
| 79 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90185688 |
| 80 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.89099245 |
| 81 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88443810 |
| 82 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86525275 |
| 83 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85766457 |
| 84 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85295115 |
| 85 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.84260950 |
| 86 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.82815190 |
| 87 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.81817591 |
| 88 | P300_27268052_Chip-Seq_Bcells_Human | 0.80993086 |
| 89 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.80193194 |
| 90 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.80192516 |
| 91 | GATA3_26560356_Chip-Seq_TH1_Human | 0.80145039 |
| 92 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.79237852 |
| 93 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77941841 |
| 94 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.77832614 |
| 95 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.77567062 |
| 96 | GATA1_19941826_ChIP-Seq_K562_Human | 0.77549170 |
| 97 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.76957337 |
| 98 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75794864 |
| 99 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.75527716 |
| 100 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.75500069 |
| 101 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.75230411 |
| 102 | GATA2_19941826_ChIP-Seq_K562_Human | 0.74826627 |
| 103 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.74322562 |
| 104 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.74251237 |
| 105 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.72975638 |
| 106 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.72659218 |
| 107 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.69327935 |
| 108 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.69304161 |
| 109 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.67643125 |
| 110 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67534734 |
| 111 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.67194559 |
| 112 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67178868 |
| 113 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65958571 |
| 114 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.64540695 |
| 115 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.63589851 |
| 116 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.63443994 |
| 117 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.61838765 |
| 118 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.61178449 |
| 119 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.59217902 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0005671_abnormal_response_to | 5.34864097 |
| 2 | MP0003763_abnormal_thymus_physiology | 4.73788745 |
| 3 | MP0006082_CNS_inflammation | 4.62955930 |
| 4 | MP0000685_abnormal_immune_system | 3.33162947 |
| 5 | * MP0001800_abnormal_humoral_immune | 3.24950500 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.21590152 |
| 7 | MP0009785_altered_susceptibility_to | 3.19025577 |
| 8 | MP0001790_abnormal_immune_system | 3.18081363 |
| 9 | MP0005387_immune_system_phenotype | 3.18081363 |
| 10 | * MP0002420_abnormal_adaptive_immunity | 2.86946234 |
| 11 | * MP0002723_abnormal_immune_serum | 2.84967773 |
| 12 | * MP0001819_abnormal_immune_cell | 2.82798153 |
| 13 | MP0009333_abnormal_splenocyte_physiolog | 2.82064346 |
| 14 | * MP0005000_abnormal_immune_tolerance | 2.79676759 |
| 15 | MP0005025_abnormal_response_to | 2.68819697 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.64178841 |
| 17 | * MP0002398_abnormal_bone_marrow | 2.62305261 |
| 18 | MP0001873_stomach_inflammation | 2.58569739 |
| 19 | MP0002405_respiratory_system_inflammati | 2.58433862 |
| 20 | MP0003866_abnormal_defecation | 2.57970317 |
| 21 | * MP0002452_abnormal_antigen_presenting | 2.50873550 |
| 22 | MP0010155_abnormal_intestine_physiology | 2.46287786 |
| 23 | MP0002166_altered_tumor_susceptibility | 2.43852598 |
| 24 | * MP0000703_abnormal_thymus_morphology | 2.38052735 |
| 25 | MP0003448_altered_tumor_morphology | 2.36624639 |
| 26 | * MP0000716_abnormal_immune_system | 2.34209557 |
| 27 | MP0003436_decreased_susceptibility_to | 2.29801759 |
| 28 | MP0002006_tumorigenesis | 2.25045254 |
| 29 | MP0003724_increased_susceptibility_to | 2.24098558 |
| 30 | * MP0002722_abnormal_immune_system | 2.19281325 |
| 31 | MP0004947_skin_inflammation | 2.05836538 |
| 32 | * MP0000689_abnormal_spleen_morphology | 2.04385195 |
| 33 | MP0002933_joint_inflammation | 2.03809560 |
| 34 | MP0002396_abnormal_hematopoietic_system | 1.91335290 |
| 35 | MP0000858_altered_metastatic_potential | 1.88728818 |
| 36 | * MP0002429_abnormal_blood_cell | 1.88576807 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.78239408 |
| 38 | MP0004510_myositis | 1.76410133 |
| 39 | MP0002419_abnormal_innate_immunity | 1.75624265 |
| 40 | * MP0001845_abnormal_inflammatory_respons | 1.72940855 |
| 41 | MP0010307_abnormal_tumor_latency | 1.64431950 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.55305844 |
| 43 | MP0003303_peritoneal_inflammation | 1.54765280 |
| 44 | MP0000490_abnormal_crypts_of | 1.37192954 |
| 45 | MP0001851_eye_inflammation | 1.33735330 |
| 46 | MP0008469_abnormal_protein_level | 1.30402867 |
| 47 | MP0002132_abnormal_respiratory_system | 1.27271644 |
| 48 | MP0010352_gastrointestinal_tract_polyps | 1.24235641 |
| 49 | MP0005310_abnormal_salivary_gland | 1.23437785 |
| 50 | MP0004808_abnormal_hematopoietic_stem | 1.20067834 |
| 51 | MP0001853_heart_inflammation | 1.19568370 |
| 52 | MP0002019_abnormal_tumor_incidence | 1.14257578 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.14198060 |
| 54 | MP0003183_abnormal_peptide_metabolism | 1.12986347 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.11912258 |
| 56 | MP0009763_increased_sensitivity_to | 1.04924068 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.01374526 |
| 58 | MP0005076_abnormal_cell_differentiation | 0.99273089 |
| 59 | MP0004381_abnormal_hair_follicle | 0.97400281 |
| 60 | MP0008961_abnormal_basal_metabolism | 0.96496927 |
| 61 | MP0001348_abnormal_lacrimal_gland | 0.90678625 |
| 62 | MP0001986_abnormal_taste_sensitivity | 0.90187598 |
| 63 | MP0003950_abnormal_plasma_membrane | 0.89844102 |
| 64 | MP0001545_abnormal_hematopoietic_system | 0.84991942 |
| 65 | MP0005397_hematopoietic_system_phenotyp | 0.84991942 |
| 66 | MP0003045_fibrosis | 0.84735033 |
| 67 | MP0005023_abnormal_wound_healing | 0.77793624 |
| 68 | MP0005451_abnormal_body_composition | 0.76694659 |
| 69 | MP0002009_preneoplasia | 0.76263179 |
| 70 | MP0002277_abnormal_respiratory_mucosa | 0.75957519 |
| 71 | MP0003828_pulmonary_edema | 0.73460739 |
| 72 | MP0000343_altered_response_to | 0.72766207 |
| 73 | MP0008873_increased_physiological_sensi | 0.68477243 |
| 74 | MP0001881_abnormal_mammary_gland | 0.67384888 |
| 75 | MP0002138_abnormal_hepatobiliary_system | 0.65434317 |
| 76 | MP0000477_abnormal_intestine_morphology | 0.64745760 |
| 77 | MP0000604_amyloidosis | 0.63931670 |
| 78 | * MP0000609_abnormal_liver_physiology | 0.63550434 |
| 79 | MP0005166_decreased_susceptibility_to | 0.62341837 |
| 80 | MP0005075_abnormal_melanosome_morpholog | 0.61991591 |
| 81 | MP0003690_abnormal_glial_cell | 0.61145904 |
| 82 | MP0003453_abnormal_keratinocyte_physiol | 0.60629703 |
| 83 | MP0000920_abnormal_myelination | 0.57090239 |
| 84 | MP0003252_abnormal_bile_duct | 0.57066041 |
| 85 | MP0003091_abnormal_cell_migration | 0.55463236 |
| 86 | MP0009765_abnormal_xenobiotic_induced | 0.54112686 |
| 87 | MP0009764_decreased_sensitivity_to | 0.53033756 |
| 88 | MP0000015_abnormal_ear_pigmentation | 0.51870287 |
| 89 | MP0009278_abnormal_bone_marrow | 0.51624657 |
| 90 | MP0002163_abnormal_gland_morphology | 0.51286918 |
| 91 | MP0001663_abnormal_digestive_system | 0.49083963 |
| 92 | MP0003191_abnormal_cellular_cholesterol | 0.48988948 |
| 93 | MP0003077_abnormal_cell_cycle | 0.48717105 |
| 94 | MP0003795_abnormal_bone_structure | 0.48611798 |
| 95 | MP0008057_abnormal_DNA_replication | 0.48155627 |
| 96 | MP0002136_abnormal_kidney_physiology | 0.47470760 |
| 97 | MP0001216_abnormal_epidermal_layer | 0.46659490 |
| 98 | MP0003566_abnormal_cell_adhesion | 0.46631899 |
| 99 | MP0000249_abnormal_blood_vessel | 0.46231356 |
| 100 | MP0001243_abnormal_dermal_layer | 0.45432842 |
| 101 | MP0008007_abnormal_cellular_replicative | 0.44779467 |
| 102 | MP0001191_abnormal_skin_condition | 0.44344531 |
| 103 | MP0002693_abnormal_pancreas_physiology | 0.44062686 |
| 104 | MP0008260_abnormal_autophagy | 0.43764445 |
| 105 | MP0004883_abnormal_blood_vessel | 0.43175834 |
| 106 | MP0004957_abnormal_blastocyst_morpholog | 0.42550285 |
| 107 | MP0003943_abnormal_hepatobiliary_system | 0.41261924 |
| 108 | MP0003172_abnormal_lysosome_physiology | 0.41106624 |
| 109 | MP0003656_abnormal_erythrocyte_physiolo | 0.39760629 |
| 110 | MP0001765_abnormal_ion_homeostasis | 0.39666306 |
| 111 | MP0005381_digestive/alimentary_phenotyp | 0.39312671 |
| 112 | MP0004142_abnormal_muscle_tone | 0.38983371 |
| 113 | MP0004130_abnormal_muscle_cell | 0.38218884 |
| 114 | MP0002822_catalepsy | 0.37167240 |
| 115 | MP0005390_skeleton_phenotype | 0.36745820 |
| 116 | MP0000598_abnormal_liver_morphology | 0.34388125 |
| 117 | MP0000627_abnormal_mammary_gland | 0.34331094 |
| 118 | MP0010234_abnormal_vibrissa_follicle | 0.33173020 |
| 119 | MP0005645_abnormal_hypothalamus_physiol | 0.32683637 |
| 120 | MP0008874_decreased_physiological_sensi | 0.32299374 |
| 121 | MP0008569_lethality_at_weaning | 0.31491480 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 6.62315943 |
| 2 | Abnormality of T cell number (HP:0011839) | 6.29789253 |
| 3 | Myositis (HP:0100614) | 5.70713514 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 5.57282056 |
| 5 | Optic neuritis (HP:0100653) | 5.57282056 |
| 6 | Nasal polyposis (HP:0100582) | 5.39914109 |
| 7 | Orchitis (HP:0100796) | 4.95795121 |
| 8 | Encephalitis (HP:0002383) | 4.82113512 |
| 9 | Abnormality of T cells (HP:0002843) | 4.72185609 |
| 10 | Hemiplegia (HP:0002301) | 4.52871320 |
| 11 | IgM deficiency (HP:0002850) | 4.45754296 |
| 12 | Increased density of long bones (HP:0006392) | 4.43814503 |
| 13 | Abnormality of the nasal mucosa (HP:0000433) | 4.41548430 |
| 14 | Recurrent bronchitis (HP:0002837) | 4.37122996 |
| 15 | Severe combined immunodeficiency (HP:0004430) | 4.30595275 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.28543087 |
| 17 | Recurrent fungal infections (HP:0002841) | 4.23468827 |
| 18 | Hypoproteinemia (HP:0003075) | 4.14387063 |
| 19 | Recurrent bacterial skin infections (HP:0005406) | 4.12982002 |
| 20 | Keratoconjunctivitis sicca (HP:0001097) | 3.99252508 |
| 21 | Combined immunodeficiency (HP:0005387) | 3.95021495 |
| 22 | Stomatitis (HP:0010280) | 3.85953042 |
| 23 | Meningitis (HP:0001287) | 3.80703802 |
| 24 | Chronic otitis media (HP:0000389) | 3.79493802 |
| 25 | Panhypogammaglobulinemia (HP:0003139) | 3.69070511 |
| 26 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.65964859 |
| 27 | Recurrent viral infections (HP:0004429) | 3.63265132 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 3.61171365 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.61171365 |
| 30 | Keratoconjunctivitis (HP:0001096) | 3.59891429 |
| 31 | Eczematoid dermatitis (HP:0000976) | 3.51009002 |
| 32 | Chronic diarrhea (HP:0002028) | 3.50881982 |
| 33 | Pulmonary infiltrates (HP:0002113) | 3.44374889 |
| 34 | Agammaglobulinemia (HP:0004432) | 3.42216279 |
| 35 | Hemoptysis (HP:0002105) | 3.41603422 |
| 36 | Abnormality of macrophages (HP:0004311) | 3.37116944 |
| 37 | Arterial thrombosis (HP:0004420) | 3.33157364 |
| 38 | Abnormality of the fingertips (HP:0001211) | 3.32834282 |
| 39 | Gastrointestinal stroma tumor (HP:0100723) | 3.31040824 |
| 40 | Increased serum ferritin (HP:0003281) | 3.26038966 |
| 41 | Hypoalbuminemia (HP:0003073) | 3.19939949 |
| 42 | Abnormal albumin level (HP:0012116) | 3.19939949 |
| 43 | Vasculitis (HP:0002633) | 3.17298908 |
| 44 | IgG deficiency (HP:0004315) | 3.13376992 |
| 45 | Abnormality of eosinophils (HP:0001879) | 3.10003909 |
| 46 | Abnormality of T cell physiology (HP:0011840) | 3.09646455 |
| 47 | Tetraplegia (HP:0002445) | 3.09082358 |
| 48 | Abnormality of the common coagulation pathway (HP:0010990) | 3.08541812 |
| 49 | Persistence of primary teeth (HP:0006335) | 3.05253717 |
| 50 | Pustule (HP:0200039) | 3.05017121 |
| 51 | Increased IgE level (HP:0003212) | 3.01105073 |
| 52 | Inflammation of the large intestine (HP:0002037) | 2.99723640 |
| 53 | Pulmonary embolism (HP:0002204) | 2.89604048 |
| 54 | Gastrointestinal inflammation (HP:0004386) | 2.88827908 |
| 55 | Autoimmune hemolytic anemia (HP:0001890) | 2.88741754 |
| 56 | Lymphoma (HP:0002665) | 2.85541750 |
| 57 | Leukocytosis (HP:0001974) | 2.85010134 |
| 58 | * Joint swelling (HP:0001386) | 2.84697993 |
| 59 | Increased CSF protein (HP:0002922) | 2.84235192 |
| 60 | Lymphopenia (HP:0001888) | 2.83461837 |
| 61 | Spontaneous hematomas (HP:0007420) | 2.81057100 |
| 62 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.77964788 |
| 63 | Abnormality of iron homeostasis (HP:0011031) | 2.74695923 |
| 64 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.72398646 |
| 65 | Eosinophilia (HP:0001880) | 2.71989584 |
| 66 | Gastrointestinal infarctions (HP:0005244) | 2.71304152 |
| 67 | Papilloma (HP:0012740) | 2.69774275 |
| 68 | Verrucae (HP:0200043) | 2.69774275 |
| 69 | IgA deficiency (HP:0002720) | 2.69224124 |
| 70 | Thyroiditis (HP:0100646) | 2.62084397 |
| 71 | Urticaria (HP:0001025) | 2.57218093 |
| 72 | Abnormality of B cell number (HP:0010975) | 2.52509719 |
| 73 | B lymphocytopenia (HP:0010976) | 2.52509719 |
| 74 | Autoimmune thrombocytopenia (HP:0001973) | 2.49709906 |
| 75 | Gangrene (HP:0100758) | 2.49458978 |
| 76 | Mediastinal lymphadenopathy (HP:0100721) | 2.47181808 |
| 77 | Bronchitis (HP:0012387) | 2.41575244 |
| 78 | Anorexia (HP:0002039) | 2.38310362 |
| 79 | Emphysema (HP:0002097) | 2.36321305 |
| 80 | Hypochromic anemia (HP:0001931) | 2.34279997 |
| 81 | Granulocytopenia (HP:0001913) | 2.34134656 |
| 82 | Cellulitis (HP:0100658) | 2.33113688 |
| 83 | Chest pain (HP:0100749) | 2.27812699 |
| 84 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.27639107 |
| 85 | Gingivitis (HP:0000230) | 2.26184164 |
| 86 | Papilledema (HP:0001085) | 2.23594492 |
| 87 | Recurrent abscess formation (HP:0002722) | 2.19458783 |
| 88 | Chronic obstructive pulmonary disease (HP:0006510) | 2.19362908 |
| 89 | Obstructive lung disease (HP:0006536) | 2.19362908 |
| 90 | Ureteral stenosis (HP:0000071) | 2.19350410 |
| 91 | Abnormality of the prostate (HP:0008775) | 2.11280045 |
| 92 | Premature loss of primary teeth (HP:0006323) | 2.11219931 |
| 93 | Recurrent skin infections (HP:0001581) | 2.10815172 |
| 94 | Restrictive lung disease (HP:0002091) | 2.10184448 |
| 95 | Cheilitis (HP:0100825) | 2.10109973 |
| 96 | Stomach cancer (HP:0012126) | 2.09457481 |
| 97 | Abnormal platelet volume (HP:0011876) | 2.09426410 |
| 98 | Recurrent sinusitis (HP:0011108) | 2.09168717 |
| 99 | Increased IgM level (HP:0003496) | 2.08787140 |
| 100 | Hypergammaglobulinemia (HP:0010702) | 2.08738479 |
| 101 | Abnormality of the endocardium (HP:0004306) | 2.02730907 |
| 102 | Hypoplasia of the thymus (HP:0000778) | 2.02209904 |
| 103 | Keratitis (HP:0000491) | 2.00846841 |
| 104 | Osteomyelitis (HP:0002754) | 2.00190916 |
| 105 | Epistaxis (HP:0000421) | 2.00107087 |
| 106 | Abnormality of the pleura (HP:0002103) | 2.00093315 |
| 107 | Basal cell carcinoma (HP:0002671) | 1.99777786 |
| 108 | Glomerulopathy (HP:0100820) | 1.99354417 |
| 109 | Skin ulcer (HP:0200042) | 1.98851619 |
| 110 | * Arthralgia (HP:0002829) | 1.98759075 |
| 111 | Increased intracranial pressure (HP:0002516) | 1.97693588 |
| 112 | Abnormality of intracranial pressure (HP:0012640) | 1.97693588 |
| 113 | Ureteral obstruction (HP:0006000) | 1.97693577 |
| 114 | Alveolar cell carcinoma (HP:0006519) | 1.96263870 |
| 115 | Prolonged bleeding time (HP:0003010) | 1.94768170 |
| 116 | Sepsis (HP:0100806) | 1.94018727 |
| 117 | Hypertriglyceridemia (HP:0002155) | 1.93837685 |
| 118 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.93108761 |
| 119 | Hyponatremia (HP:0002902) | 1.91417802 |
| 120 | Thrombocytosis (HP:0001894) | 1.90263473 |
| 121 | Gingival bleeding (HP:0000225) | 1.88815204 |
| 122 | Chronic sinusitis (HP:0011109) | 1.87400977 |
| 123 | Colitis (HP:0002583) | 1.86368031 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 7.62432053 |
| 2 | MAP4K1 | 5.11015840 |
| 3 | JAK3 | 3.45635505 |
| 4 | ITK | 3.32027469 |
| 5 | RIPK4 | 3.25023724 |
| 6 | PRPF4B | 3.10032992 |
| 7 | STK10 | 2.77483874 |
| 8 | FGFR4 | 2.70806856 |
| 9 | ZAP70 | 2.58086338 |
| 10 | TYK2 | 2.40902191 |
| 11 | GRK7 | 2.09489027 |
| 12 | GRK6 | 1.93703951 |
| 13 | * JAK1 | 1.87275989 |
| 14 | IKBKE | 1.85341750 |
| 15 | FGFR3 | 1.83280679 |
| 16 | MAP3K14 | 1.81257777 |
| 17 | EEF2K | 1.77688426 |
| 18 | EPHB1 | 1.71185877 |
| 19 | * LCK | 1.64706513 |
| 20 | TAOK3 | 1.59829880 |
| 21 | CSK | 1.52185024 |
| 22 | EPHA3 | 1.50701909 |
| 23 | NLK | 1.45639959 |
| 24 | MST4 | 1.45169246 |
| 25 | MAP3K10 | 1.43764502 |
| 26 | TBK1 | 1.42500977 |
| 27 | TRIB3 | 1.41211144 |
| 28 | ERN1 | 1.39635897 |
| 29 | IRAK3 | 1.39204637 |
| 30 | TEC | 1.37405192 |
| 31 | PRKCH | 1.34817526 |
| 32 | BTK | 1.33679363 |
| 33 | HCK | 1.29124404 |
| 34 | PRKCQ | 1.27244207 |
| 35 | KDR | 1.27127329 |
| 36 | BMPR2 | 1.26928401 |
| 37 | PIM1 | 1.23047297 |
| 38 | CDK12 | 1.21925899 |
| 39 | SYK | 1.19614596 |
| 40 | SIK2 | 1.18820414 |
| 41 | ADRBK2 | 1.18499776 |
| 42 | FES | 1.17717047 |
| 43 | TESK2 | 1.16047106 |
| 44 | MAP2K2 | 1.11593854 |
| 45 | MARK3 | 1.07065519 |
| 46 | CDK4 | 1.01242306 |
| 47 | JAK2 | 0.97897438 |
| 48 | LRRK2 | 0.96154663 |
| 49 | KIT | 0.93169430 |
| 50 | PKN2 | 0.89986873 |
| 51 | TNK2 | 0.87879904 |
| 52 | MAP3K7 | 0.87114702 |
| 53 | FGR | 0.86705759 |
| 54 | RPS6KA4 | 0.86582450 |
| 55 | MAP3K13 | 0.86299222 |
| 56 | IKBKB | 0.83987646 |
| 57 | TLK1 | 0.82443897 |
| 58 | TTN | 0.79209645 |
| 59 | BLK | 0.78835611 |
| 60 | CLK1 | 0.77825449 |
| 61 | ALK | 0.72886590 |
| 62 | SMG1 | 0.72825321 |
| 63 | CHUK | 0.69240931 |
| 64 | TYRO3 | 0.68547550 |
| 65 | MAPK12 | 0.68521414 |
| 66 | LYN | 0.65725578 |
| 67 | MAPK7 | 0.63461189 |
| 68 | CDC42BPA | 0.63294239 |
| 69 | SIK3 | 0.60785801 |
| 70 | TSSK6 | 0.60709108 |
| 71 | BRD4 | 0.59036431 |
| 72 | PDGFRB | 0.58166562 |
| 73 | FGFR1 | 0.57538216 |
| 74 | MOS | 0.57268828 |
| 75 | TAOK1 | 0.57034201 |
| 76 | MATK | 0.53749521 |
| 77 | TGFBR2 | 0.53732095 |
| 78 | DMPK | 0.51866800 |
| 79 | MELK | 0.50578288 |
| 80 | SIK1 | 0.50453553 |
| 81 | IRAK4 | 0.50429481 |
| 82 | CAMKK1 | 0.49350916 |
| 83 | HIPK2 | 0.49333334 |
| 84 | CAMKK2 | 0.48170697 |
| 85 | MAP3K11 | 0.47376551 |
| 86 | IRAK1 | 0.47020853 |
| 87 | PTK6 | 0.46190554 |
| 88 | EIF2AK2 | 0.44910551 |
| 89 | PDK1 | 0.44902004 |
| 90 | STK24 | 0.44411249 |
| 91 | RIPK1 | 0.43773163 |
| 92 | CDK6 | 0.43271889 |
| 93 | CDK3 | 0.42390700 |
| 94 | CDK9 | 0.40975117 |
| 95 | MAP3K1 | 0.40677922 |
| 96 | FYN | 0.39397378 |
| 97 | CSF1R | 0.39157492 |
| 98 | MAP3K3 | 0.38317562 |
| 99 | MARK2 | 0.38178584 |
| 100 | MAP2K6 | 0.37898413 |
| 101 | TAOK2 | 0.37726741 |
| 102 | MAP3K8 | 0.35852986 |
| 103 | GSK3A | 0.31206418 |
| 104 | PIK3CG | 0.30564660 |
| 105 | PDPK1 | 0.30319012 |
| 106 | NEK2 | 0.30311646 |
| 107 | PRKD2 | 0.29792495 |
| 108 | KSR2 | 0.28675711 |
| 109 | BMX | 0.28047546 |
| 110 | MAP2K3 | 0.27339193 |
| 111 | RPS6KL1 | 0.26540762 |
| 112 | RPS6KC1 | 0.26540762 |
| 113 | RET | 0.26467816 |
| 114 | * IGF1R | 0.26343137 |
| 115 | ABL1 | 0.24212361 |
| 116 | SGK3 | 0.24135107 |
| 117 | RPS6KA6 | 0.23912369 |
| 118 | MAPKAPK2 | 0.23297001 |
| 119 | YES1 | 0.22727083 |
| 120 | MAPK11 | 0.22711660 |
| 121 | * INSR | 0.22153472 |
| 122 | MAPK4 | 0.21647893 |
| 123 | STK11 | 0.20845143 |
| 124 | NEK6 | 0.20259349 |
| 125 | TRPM7 | 0.20137907 |
| 126 | PASK | 0.19235695 |
| 127 | RPS6KA5 | 0.18585375 |
| 128 | EGFR | 0.18215926 |
| 129 | NUAK1 | 0.17658800 |
| 130 | MAPK3 | 0.17463401 |
| 131 | SRC | 0.15282528 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 6.07529971 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 4.59320714 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 4.14978701 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.99638754 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.93099944 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.57531571 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.17203790 |
| 8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.15143202 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.65457730 |
| 10 | Viral myocarditis_Homo sapiens_hsa05416 | 2.50337516 |
| 11 | * Measles_Homo sapiens_hsa05162 | 2.19805460 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.07305854 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.80724541 |
| 14 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.79112043 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.78854717 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.65289722 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.55293662 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.47416887 |
| 19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.38150919 |
| 20 | Apoptosis_Homo sapiens_hsa04210 | 1.30237534 |
| 21 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23252872 |
| 22 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.22985799 |
| 23 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.18069133 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.13261324 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.13058453 |
| 26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.11055311 |
| 27 | Shigellosis_Homo sapiens_hsa05131 | 1.06320548 |
| 28 | Hepatitis B_Homo sapiens_hsa05161 | 1.06051798 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.04655558 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.03810108 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.02809131 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.99444909 |
| 33 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.98924016 |
| 34 | Malaria_Homo sapiens_hsa05144 | 0.98016775 |
| 35 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.95719828 |
| 36 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.94623206 |
| 37 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.93874331 |
| 38 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.89499679 |
| 39 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.89324822 |
| 40 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88455070 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 0.87795881 |
| 42 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.85360207 |
| 43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.85251840 |
| 44 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.80298897 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.78672597 |
| 46 | Colorectal cancer_Homo sapiens_hsa05210 | 0.77804336 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 0.76583614 |
| 48 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.74033993 |
| 49 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.70785672 |
| 50 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.67615205 |
| 51 | Legionellosis_Homo sapiens_hsa05134 | 0.65501482 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64592219 |
| 53 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63431294 |
| 54 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62981057 |
| 55 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61808056 |
| 56 | Tuberculosis_Homo sapiens_hsa05152 | 0.60545857 |
| 57 | Hepatitis C_Homo sapiens_hsa05160 | 0.58710477 |
| 58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58147270 |
| 59 | Pertussis_Homo sapiens_hsa05133 | 0.56961267 |
| 60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55801325 |
| 61 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.55443018 |
| 62 | Salmonella infection_Homo sapiens_hsa05132 | 0.55113167 |
| 63 | Asthma_Homo sapiens_hsa05310 | 0.54935960 |
| 64 | Phagosome_Homo sapiens_hsa04145 | 0.54393696 |
| 65 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.51258497 |
| 66 | * Endocytosis_Homo sapiens_hsa04144 | 0.49908919 |
| 67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48843999 |
| 68 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.44802085 |
| 69 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.43289862 |
| 70 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40033759 |
| 71 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39437930 |
| 72 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38806038 |
| 73 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.36328029 |
| 74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35701617 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.35423587 |
| 76 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35138322 |
| 77 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.33414569 |
| 78 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33317003 |
| 79 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32451952 |
| 80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31324916 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31268762 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29329500 |
| 83 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.28483668 |
| 84 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.27829973 |
| 85 | Other glycan degradation_Homo sapiens_hsa00511 | 0.27225619 |
| 86 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.26038480 |
| 87 | Prostate cancer_Homo sapiens_hsa05215 | 0.25220982 |
| 88 | Spliceosome_Homo sapiens_hsa03040 | 0.24733008 |
| 89 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23976288 |
| 90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.22886565 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.22666924 |
| 92 | Focal adhesion_Homo sapiens_hsa04510 | 0.21183724 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.20762995 |
| 94 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.20652556 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.20523685 |
| 96 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.19876322 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.19453023 |
| 98 | Adherens junction_Homo sapiens_hsa04520 | 0.18254813 |
| 99 | Pathways in cancer_Homo sapiens_hsa05200 | 0.18154342 |
| 100 | RNA degradation_Homo sapiens_hsa03018 | 0.16846978 |
| 101 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.16441281 |
| 102 | Endometrial cancer_Homo sapiens_hsa05213 | 0.16143525 |
| 103 | Lysine degradation_Homo sapiens_hsa00310 | 0.16077044 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.15850690 |
| 105 | Circadian rhythm_Homo sapiens_hsa04710 | 0.15327574 |
| 106 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.14412476 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.14271321 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.13690991 |
| 109 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.13443772 |
| 110 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.11074954 |
| 111 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.09763082 |
| 112 | ABC transporters_Homo sapiens_hsa02010 | 0.09201145 |
| 113 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.08872874 |
| 114 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.08772417 |
| 115 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.08731743 |
| 116 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.08113264 |

